Labcorp (LH)
(Delayed Data from NYSE)
$230.70 USD
+0.49 (0.21%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $230.88 +0.18 (0.08%) 7:18 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for Labcorp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 419.20 | 1,280.60 | 2,379.50 | 1,557.00 | 824.90 |
Depreciation/Amortization & Depletion | 577.30 | 905.40 | 745.10 | 1,086.80 | 771.30 |
Net Change from Assets/Liabilities | -323.00 | -603.40 | -263.70 | -856.90 | -300.90 |
Net Cash from Discontinued Operations | 86.60 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 567.60 | 373.30 | 248.70 | 348.40 | 149.40 |
Net Cash From Operating Activities | 1,327.70 | 1,955.90 | 3,109.60 | 2,135.30 | 1,444.70 |
Property & Equipment | -453.00 | -480.50 | -373.10 | -339.60 | -392.50 |
Acquisition/ Disposition of Subsidiaries | -671.50 | -1,162.40 | -496.90 | -267.60 | -876.00 |
Investments | -22.30 | -17.40 | -27.80 | -39.10 | -16.30 |
Other Investing Activities | -24.70 | 8.10 | 13.20 | 3.10 | 1.70 |
Net Cash from Investing Activities | -1,171.50 | -1,652.20 | -884.60 | -643.20 | -1,283.10 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -945.60 | -1,049.40 | -1,616.80 | -44.10 | -385.30 |
Issuance (Repayment) of Debt | -300.00 | 0.00 | -375.00 | -412.20 | 210.10 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -254.00 | -195.20 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 1,440.30 | -77.60 | -74.00 | -61.10 | -77.50 |
Net Cash from Financing Activities | -59.30 | -1,322.20 | -2,065.80 | -517.40 | -252.70 |
Effect of Exchange Rate Changes | 9.90 | -24.20 | -7.30 | 8.60 | 1.80 |
Net Change In Cash & Equivalents | 106.80 | -1,042.70 | 151.90 | 983.30 | -89.30 |
Cash at Beginning of Period | 430.00 | 1,472.70 | 1,320.80 | 337.50 | 426.80 |
Cash at End of Period | 536.80 | 430.00 | 1,472.70 | 1,320.80 | 337.50 |
Diluted Net EPS | 4.77 | 13.97 | 24.39 | 15.88 | 8.35 |
Fiscal Year End for Labcorp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 433.90 | 228.30 | 419.20 | 586.00 | 402.40 |
Depreciation/Amortization & Depletion | 311.40 | 154.50 | 577.30 | 430.90 | 290.00 |
Net Change from Assets/Liabilities | -365.00 | -468.30 | -323.00 | -586.50 | -478.10 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 86.60 | 86.60 | 86.60 |
Other Operating Activities | 151.00 | 55.70 | 567.60 | 231.10 | 171.70 |
Net Cash From Operating Activities | 531.30 | -29.80 | 1,327.70 | 748.10 | 472.60 |
Property & Equipment | -261.80 | -133.70 | -453.00 | -286.10 | -181.30 |
Acquisition/ Disposition of Subsidiaries | -279.60 | -245.70 | -671.50 | -516.70 | -136.90 |
Investments | -36.70 | -13.70 | -22.30 | -13.40 | -10.40 |
Other Investing Activities | 0.00 | 0.00 | -24.70 | -24.70 | -24.70 |
Net Cash from Investing Activities | -578.10 | -393.10 | -1,171.50 | -840.90 | -353.30 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -73.30 | 26.70 | -945.60 | -954.60 | 54.40 |
Issuance (Repayment) of Debt | 19.80 | 42.40 | -300.00 | 89.60 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -122.50 | -62.10 | -254.00 | -192.90 | -129.00 |
Other Financing Activities | -45.70 | -18.70 | 1,440.30 | 1,445.10 | 1,559.00 |
Net Cash from Financing Activities | -221.70 | -11.70 | -59.30 | 387.20 | 1,484.40 |
Effect of Exchange Rate Changes | -3.20 | -2.90 | 9.90 | 3.50 | 6.30 |
Net Change In Cash & Equivalents | -271.70 | -437.50 | 106.80 | 297.90 | 1,610.00 |
Cash at Beginning of Period | 536.80 | 536.80 | 430.00 | 430.00 | 320.60 |
Cash at End of Period | 265.10 | 99.30 | 536.80 | 727.90 | 1,930.60 |
Diluted Net EPS | 2.43 | 2.69 | -1.85 | 2.11 | 2.12 |